New Zealand Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others
Summary
GlobalData’s new report, “New Zealand Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others” provides key market data on the New Zealand Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
Reasons to buy
Summary
GlobalData’s new report, “New Zealand Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others” provides key market data on the New Zealand Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Neurology Devices market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within five market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the six market categories.
- Global corporate-level profiles of key companies operating within the New Zealand Neurology Devicesmarket.
- Key players covered include Medtronic, Inc., Terumo Corporation, B. Braun Melsungen AG, Stryker Corporation, DePuy, Inc., Nihon Kohden Corporation and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the New Zealand Neurology Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 INTRODUCTION
2.1 What is This Report About?
3 NEUROLOGY DEVICES IN NEW ZEALAND
3.1 Neurology Devices, Market Segmentation
3.2 Neurology Devices, New Zealand, Overall Revenue ($m), USD Constant, 2004-2018
3.3 Neurology Devices Market, New Zealand, Revenue Mix ($m), 2011
3.4 Neurology Devices Market, New Zealand, Category Contribution (%), 2011
3.5 Neurology Devices, New Zealand, Company Share (2010-2011)
4 CSF MANAGEMENT IN NEW ZEALAND
4.1 CSF Management, Market Segmentation
4.2 CSF Management Market, New Zealand, Revenue Mix ($m), 2011
4.3 CSF Management Market, New Zealand, Segment Contribution (%), 2011
4.4 CSF Management Overall Revenue, (2004-2018)
4.5 CSF Management Overall Volume (2004-2018)
4.6 CSF Management Average Price (2004-2018)
4.7 CSF Management Distribution Share (2010-2011)
4.8 CSF Management, New Zealand, Company Share (2010-2011)
5 INTERVENTIONAL NEUROLOGY IN NEW ZEALAND
5.1 Interventional Neurology, Market.Segmentation
5.2 Interventional Neurology Market, New Zealand, Revenue Mix ($m), 2011
5.3 Interventional Neurology Market, New Zealand, Segment Contribution (%), 2011
5.4 Interventional Neurology Overall Revenue, (2004-2018)
5.4.1 Embolic Systems Revenue (2004-2018)
5.4.2 Navigational Systems Revenue (2004-2018)
5.5 Interventional Neurology Overall Volume (2004-2018)
5.5.1 Embolic Systems Volume (2004-2018)
5.5.2 Navigational Systems Volume (2004-2018)
5.6 Interventional Neurology Average Price (2004-2018)
5.7 Interventional Neurology Distribution Share (2010-2011)
5.8 Interventional Neurology, New Zealand, Company Share (2010-2011)
6 NEUROLOGICAL DIAGNOSTIC EQUIPMENT IN NEW ZEALAND
6.1 Neurological Diagnostic Equipment, Market.Segmentation
6.2 Neurological Diagnostic Equipment Market, New Zealand, Revenue Mix ($m), 2011
6.3 Neurological Diagnostic Equipment Market, New Zealand, Segment Contribution (%), 2011
6.4 Neurological Diagnostic Equipment Overall Revenue, (2004-2018)
6.5 Neurological Diagnostic Equipment Overall Volume (2004-2018)
6.6 Neurological Diagnostic Equipment Average Price (2004-2018)
6.7 Neurological Diagnostic Equipment Distribution Share (2010-2011)
6.8 Neurological Diagnostic Equipment, New Zealand, Company Share (2010-2011)
7 NEUROSTIMULATION DEVICES IN NEW ZEALAND
7.1 Neurostimulation Devices, Market Segmentation
7.2 Neurostimulation Devices Market, New Zealand, Revenue Mix ($m), 2011
7.3 Neurostimulation Devices Market, New Zealand, Segment Contribution (%), 2011
7.4 Neurostimulation Devices Overall Revenue, (2004-2018)
7.5 Neurostimulation Devices Overall Volume (2004-2018)
7.6 Neurostimulation Devices Average Price (2004-2018)
7.7 Neurostimulation Devices Distribution Share (2010-2011)
7.8 Neurostimulation Devices, New Zealand, Company Share (2010-2011)
8 NEUROSURGICAL PRODUCTS IN NEW ZEALAND
8.1 Neurosurgical Products, Market Segmentation
8.2 Neurosurgical Products Market, New Zealand, Revenue Mix ($m), 2011
8.3 Neurosurgical Products Market, New Zealand, Segment Contribution (%), 2011
8.4 Neurosurgical Products Overall Revenue, (2004-2018)
8.5 Neurosurgical Products Overall Volume (2004-2018)
8.6 Neurosurgical Products Average Price (2004-2018)
8.7 Neurosurgical Products Distribution Share (2010-2011)
8.8 Neurosurgical Products, New Zealand, Company Share (2010-2011)
9 OVERVIEW OF KEY COMPANIES IN NEW ZEALAND NEUROLOGY DEVICES MARKET
9.1 Medtronic, Inc.
9.1.1 Company Overview
9.1.2 Share in the New Zealand Neurology Devices Market
9.2 Terumo Corporation
9.2.1 Company Overview
9.2.2 Share in the New Zealand Neurology Devices Market
9.3 B. Braun Melsungen AG
9.3.1 Company Overview
9.3.2 Share in the New Zealand Neurology Devices Market
9.4 Stryker Corporation
9.4.1 Company Overview
9.4.2 Share in the New Zealand Neurology Devices Market
9.5 Nihon Kohden Corporation
9.5.1 Company Overview
9.5.2 Share in the New Zealand Neurology Devices Market
9.6 DePuy, Inc.
9.6.1 Company Overview
9.6.2 Share in the New Zealand Neurology Devices Market
9.7 Boston Scientific Corporation
9.7.1 Company Overview
9.8 Integra LifeSciences Holdings Corporation
9.8.1 Company Overview
9.9 Compumedics Limited
9.9.1 Company Overview
9.10 Natus Medical Incorporated
9.10.1 Company Overview
9.11 CareFusion Corporation
9.11.1 Company Overview
9.12 Christoph Miethke GmbH & Co. KG
9.12.1 Company Overview
9.13 Cadwell Laboratories, Inc.
9.13.1 Company Overview
9.14 KARL STORZ GmbH & Co. KG
9.14.1 Company Overview
9.15 St. Jude Medical, Inc.
9.15.1 Company Overview
9.16 Sophysa S.A.
9.16.1 Company Overview
9.17 Covidien plc
9.17.1 Company Overview
10 NEUROLOGY DEVICES MARKET PIPELINE PRODUCTS
11 APPENDIX
11.1 Definitions of Markets Covered in the Report
11.1.1 Neurology Devices
11.2 Research Methodology
11.3 Secondary Research
11.4 Primary Research
11.5 Models
11.6 Forecasts
11.7 Expert Panels
11.8 GlobalData Consulting
11.9 Currency Conversion
11.10 Contact Us
11.11 Disclaimer
LIST OF TABLES
Table 1: Neurology Devices, New Zealand, Overall Revenue ($m), USD Constant, 2004-2018
Table 2: Neurology Devices Market, New Zealand, Category Contribution (%), 2011
Table 3: Neurology Devices, New Zealand, Cross-Category Analysis, 2004-2018
Table 4: Neurology Devices, New Zealand, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 5: Neurology Devices, New Zealand, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 6: Neurology Devices, New Zealand, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 7: CSF Management Market, New Zealand, Segment Contribution (%), 2011
Table 8: CSF Management, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 9: CSF Management, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 10: CSF Management, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Table 11: CSF Management, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Table 12: CSF Management, New Zealand, Average Price ($), Historic, 2004-2011
Table 13: CSF Management, New Zealand, Average Price ($), Forecast, 2011-2018
Table 14: CSF Management, New Zealand, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 15: CSF Management, New Zealand, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 16: Interventional Neurology Market, New Zealand, Segment Contribution (%), 2011
Table 17: Interventional Neurology, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 18: Interventional Neurology, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 19: Embolic Systems, New Zealand, Revenue ($m*) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 20: Embolic Systems, New Zealand, Revenue ($m*) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 21: Navigational Systems, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 22: Navigational Systems, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 23: Interventional Neurology, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Table 24: Interventional Neurology, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Table 25: Embolic Systems, New Zealand, Volume (Units) by Sub-Segment, Historic, 2004-2011
Table 26: Embolic Systems, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Table 27: Navigational Systems, New Zealand, Volume (Units) by Sub-Segment, Historic, 2004-2011
Table 28: Navigational Systems, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Table 29: Interventional Neurology, New Zealand, Average Price ($), Historic, 2004-2011
Table 30: Interventional Neurology, New Zealand, Average Price ($), Forecast, 2011-2018
Table 31: Interventional Neurology, New Zealand, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 32: Interventional Neurology, New Zealand, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 33: Neurological Diagnostic Equipment Market, New Zealand, Segment Contribution (%), 2011
Table 34: Neurological Diagnostic Equipment, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 35: Neurological Diagnostic Equipment, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 36: Neurological Diagnostic Equipment, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Table 37: Neurological Diagnostic Equipment, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Table 38: Neurological Diagnostic Equipment, New Zealand, Average Price ($), Historic, 2004-2011
Table 39: Neurological Diagnostic Equipment, New Zealand, Average Price ($), Forecast, 2011-2018
Table 40: Neurological Diagnostic Equipment, New Zealand, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 41: Neurological Diagnostic Equipment, New Zealand, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 42: Neurostimulation Devices Market, New Zealand, Segment Contribution (%), 2011
Table 43: Neurostimulation Devices, New Zealand, Revenue ($m*) USD Constant, by Segment, Historic, 2004-2011
Table 44: Neurostimulation Devices, New Zealand, Revenue ($m*) USD Constant, by Segment, Forecast, 2011-2018
Table 45: Neurostimulation Devices, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Table 46: Neurostimulation Devices, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Table 47: Neurostimulation Devices, New Zealand, Average Price ($), Historic, 2004-2011
Table 48: Neurostimulation Devices, New Zealand, Average Price ($), Forecast, 2011-2018
Table 49: Neurostimulation Devices, New Zealand, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 50: Neurostimulation Devices, New Zealand, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 51: Neurosurgical Products Market, New Zealand, Segment Contribution (%), 2011
Table 52: Neurosurgical Products, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 53: Neurosurgical Products, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 54: Neurosurgical Products, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Table 55: Neurosurgical Products, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Table 56: Neurosurgical Products, New Zealand, Average Price ($), Historic, 2004-2011
Table 57: Neurosurgical Products, New Zealand, Average Price ($), Forecast, 2011-2018
Table 58: Neurosurgical Products, New Zealand, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 59: Neurosurgical Products, New Zealand, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 60: Neurology Devices Market Pipeline Products
LIST OF FIGURES
Figure 1: Neurology Devices, Market Segmentation
Figure 2: Neurology Devices, New Zealand, Overall Revenue ($m), USD Constant, 2004-2018
Figure 3: Neurology Devices Market, New Zealand, Revenue Mix ($m), 2011
Figure 4: Neurology Devices Market, New Zealand, Category Contribution (%), 2011
Figure 5: Neurology Devices, New Zealand, Cross-Category Analysis, 2004-2018
Figure 6: Neurology Devices, New Zealand, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 7: Neurology Devices, New Zealand, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 8: Neurology Devices, New Zealand, Company Share (%), 2011
Figure 9: CSF Management, Market Segmentation
Figure 10: CSF Management Market, New Zealand, Revenue Mix ($m), 2011
Figure 11: CSF Management Market, New Zealand, Segment Contribution (%), 2011
Figure 12: CSF Management, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 13: CSF Management, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 14: CSF Management, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Figure 15: CSF Management, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Figure 16: CSF Management, New Zealand, Company Share (%), 2011
Figure 17: Interventional Neurology, Market Segmentation
Figure 18: Interventional Neurology Market, New Zealand, Revenue Mix ($m), 2011
Figure 19: Interventional Neurology Market, New Zealand, Segment Contribution (%), 2011
Figure 20: Interventional Neurology, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 21: Interventional Neurology, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 22: Embolic Systems, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 23: Embolic Systems, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 24: Navigational Systems, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 25: Navigational Systems, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 26: Interventional Neurology, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Figure 27: Interventional Neurology, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Figure 28: Embolic Systems, New Zealand, Volume (Units) by Sub-Segment, Historic, 2004-2011
Figure 29: Embolic Systems, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Figure 30: Navigational Systems, New Zealand, Volume (Units) by Sub-Segment, Historic, 2004-2011
Figure 31: Navigational Systems, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Figure 32: Interventional Neurology, New Zealand, Company Share (%), 2011
Figure 33: Neurological Diagnostic Equipment, Market Segmentation
Figure 34: Neurological Diagnostic Equipment Market, New Zealand, Revenue Mix ($m), 2011
Figure 35: Neurological Diagnostic Equipment Market, New Zealand, Segment Contribution (%), 2011
Figure 36: Neurological Diagnostic Equipment, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 37: Neurological Diagnostic Equipment, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 38: Neurological Diagnostic Equipment, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Figure 39: Neurological Diagnostic Equipment, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Figure 40: Neurological Diagnostic Equipment, New Zealand, Company Share (%), 2011
Figure 41: Neurostimulation Devices, Market Segmentation
Figure 42: Neurostimulation Devices Market, New Zealand, Revenue Mix ($m), 2011
Figure 43: Neurostimulation Devices Market, New Zealand, Segment Contribution (%), 2011
Figure 44: Neurostimulation Devices, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 45: Neurostimulation Devices, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 46: Neurostimulation Devices, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Figure 47: Neurostimulation Devices, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Figure 48: Neurostimulation Devices, New Zealand, Company Share (%), 2011
Figure 49: Neurosurgical Products, Market Segmentation
Figure 50: Neurosurgical Products Market, New Zealand, Revenue Mix ($m), 2011
Figure 51: Neurosurgical Products Market, New Zealand, Segment Contribution (%), 2011
Figure 52: Neurosurgical Products, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 53: Neurosurgical Products, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 54: Neurosurgical Products, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Figure 55: Neurosurgical Products, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Figure 56: Neurosurgical Products, New Zealand, Company Share (%), 2011
Figure 57: Medtronic, Inc., Company Share (%),New Zealand Neurology Devices Market, 2011
Figure 58: Terumo Corporation, Company Share (%),New Zealand Neurology Devices Market, 2011
Figure 59: B. Braun Melsungen AG, Company Share (%),New Zealand Neurology Devices Market, 2011
Figure 60: Stryker Corporation, Company Share (%),New Zealand Neurology Devices Market, 2011
Figure 61: Nihon Kohden Corporation, Company Share (%),New Zealand Neurology Devices Market, 2011
Figure 62: DePuy, Inc., Company Share (%),New Zealand Neurology Devices Market, 2011
COMPANIES MENTIONED
Medtronic, Inc.
Terumo Corporation
B. Braun Melsungen AG
Stryker Corporation
Nihon Kohden Corporation
DePuy, Inc.
Boston Scientific Corporation
Integra LifeSciences Holdings Corporation
Compumedics Limited
Natus Medical Incorporated
CareFusion Corporation
Christoph Miethke GmbH & Co. KG
Cadwell Laboratories, Inc.
KARL STORZ GmbH & Co. KG
St. Jude Medical, Inc.
Sophysa S.A.
Covidien plc
1.1 List of Tables
1.2 List of Figures
2 INTRODUCTION
2.1 What is This Report About?
3 NEUROLOGY DEVICES IN NEW ZEALAND
3.1 Neurology Devices, Market Segmentation
3.2 Neurology Devices, New Zealand, Overall Revenue ($m), USD Constant, 2004-2018
3.3 Neurology Devices Market, New Zealand, Revenue Mix ($m), 2011
3.4 Neurology Devices Market, New Zealand, Category Contribution (%), 2011
3.5 Neurology Devices, New Zealand, Company Share (2010-2011)
4 CSF MANAGEMENT IN NEW ZEALAND
4.1 CSF Management, Market Segmentation
4.2 CSF Management Market, New Zealand, Revenue Mix ($m), 2011
4.3 CSF Management Market, New Zealand, Segment Contribution (%), 2011
4.4 CSF Management Overall Revenue, (2004-2018)
4.5 CSF Management Overall Volume (2004-2018)
4.6 CSF Management Average Price (2004-2018)
4.7 CSF Management Distribution Share (2010-2011)
4.8 CSF Management, New Zealand, Company Share (2010-2011)
5 INTERVENTIONAL NEUROLOGY IN NEW ZEALAND
5.1 Interventional Neurology, Market.Segmentation
5.2 Interventional Neurology Market, New Zealand, Revenue Mix ($m), 2011
5.3 Interventional Neurology Market, New Zealand, Segment Contribution (%), 2011
5.4 Interventional Neurology Overall Revenue, (2004-2018)
5.4.1 Embolic Systems Revenue (2004-2018)
5.4.2 Navigational Systems Revenue (2004-2018)
5.5 Interventional Neurology Overall Volume (2004-2018)
5.5.1 Embolic Systems Volume (2004-2018)
5.5.2 Navigational Systems Volume (2004-2018)
5.6 Interventional Neurology Average Price (2004-2018)
5.7 Interventional Neurology Distribution Share (2010-2011)
5.8 Interventional Neurology, New Zealand, Company Share (2010-2011)
6 NEUROLOGICAL DIAGNOSTIC EQUIPMENT IN NEW ZEALAND
6.1 Neurological Diagnostic Equipment, Market.Segmentation
6.2 Neurological Diagnostic Equipment Market, New Zealand, Revenue Mix ($m), 2011
6.3 Neurological Diagnostic Equipment Market, New Zealand, Segment Contribution (%), 2011
6.4 Neurological Diagnostic Equipment Overall Revenue, (2004-2018)
6.5 Neurological Diagnostic Equipment Overall Volume (2004-2018)
6.6 Neurological Diagnostic Equipment Average Price (2004-2018)
6.7 Neurological Diagnostic Equipment Distribution Share (2010-2011)
6.8 Neurological Diagnostic Equipment, New Zealand, Company Share (2010-2011)
7 NEUROSTIMULATION DEVICES IN NEW ZEALAND
7.1 Neurostimulation Devices, Market Segmentation
7.2 Neurostimulation Devices Market, New Zealand, Revenue Mix ($m), 2011
7.3 Neurostimulation Devices Market, New Zealand, Segment Contribution (%), 2011
7.4 Neurostimulation Devices Overall Revenue, (2004-2018)
7.5 Neurostimulation Devices Overall Volume (2004-2018)
7.6 Neurostimulation Devices Average Price (2004-2018)
7.7 Neurostimulation Devices Distribution Share (2010-2011)
7.8 Neurostimulation Devices, New Zealand, Company Share (2010-2011)
8 NEUROSURGICAL PRODUCTS IN NEW ZEALAND
8.1 Neurosurgical Products, Market Segmentation
8.2 Neurosurgical Products Market, New Zealand, Revenue Mix ($m), 2011
8.3 Neurosurgical Products Market, New Zealand, Segment Contribution (%), 2011
8.4 Neurosurgical Products Overall Revenue, (2004-2018)
8.5 Neurosurgical Products Overall Volume (2004-2018)
8.6 Neurosurgical Products Average Price (2004-2018)
8.7 Neurosurgical Products Distribution Share (2010-2011)
8.8 Neurosurgical Products, New Zealand, Company Share (2010-2011)
9 OVERVIEW OF KEY COMPANIES IN NEW ZEALAND NEUROLOGY DEVICES MARKET
9.1 Medtronic, Inc.
9.1.1 Company Overview
9.1.2 Share in the New Zealand Neurology Devices Market
9.2 Terumo Corporation
9.2.1 Company Overview
9.2.2 Share in the New Zealand Neurology Devices Market
9.3 B. Braun Melsungen AG
9.3.1 Company Overview
9.3.2 Share in the New Zealand Neurology Devices Market
9.4 Stryker Corporation
9.4.1 Company Overview
9.4.2 Share in the New Zealand Neurology Devices Market
9.5 Nihon Kohden Corporation
9.5.1 Company Overview
9.5.2 Share in the New Zealand Neurology Devices Market
9.6 DePuy, Inc.
9.6.1 Company Overview
9.6.2 Share in the New Zealand Neurology Devices Market
9.7 Boston Scientific Corporation
9.7.1 Company Overview
9.8 Integra LifeSciences Holdings Corporation
9.8.1 Company Overview
9.9 Compumedics Limited
9.9.1 Company Overview
9.10 Natus Medical Incorporated
9.10.1 Company Overview
9.11 CareFusion Corporation
9.11.1 Company Overview
9.12 Christoph Miethke GmbH & Co. KG
9.12.1 Company Overview
9.13 Cadwell Laboratories, Inc.
9.13.1 Company Overview
9.14 KARL STORZ GmbH & Co. KG
9.14.1 Company Overview
9.15 St. Jude Medical, Inc.
9.15.1 Company Overview
9.16 Sophysa S.A.
9.16.1 Company Overview
9.17 Covidien plc
9.17.1 Company Overview
10 NEUROLOGY DEVICES MARKET PIPELINE PRODUCTS
11 APPENDIX
11.1 Definitions of Markets Covered in the Report
11.1.1 Neurology Devices
11.2 Research Methodology
11.3 Secondary Research
11.4 Primary Research
11.5 Models
11.6 Forecasts
11.7 Expert Panels
11.8 GlobalData Consulting
11.9 Currency Conversion
11.10 Contact Us
11.11 Disclaimer
LIST OF TABLES
Table 1: Neurology Devices, New Zealand, Overall Revenue ($m), USD Constant, 2004-2018
Table 2: Neurology Devices Market, New Zealand, Category Contribution (%), 2011
Table 3: Neurology Devices, New Zealand, Cross-Category Analysis, 2004-2018
Table 4: Neurology Devices, New Zealand, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 5: Neurology Devices, New Zealand, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 6: Neurology Devices, New Zealand, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 7: CSF Management Market, New Zealand, Segment Contribution (%), 2011
Table 8: CSF Management, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 9: CSF Management, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 10: CSF Management, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Table 11: CSF Management, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Table 12: CSF Management, New Zealand, Average Price ($), Historic, 2004-2011
Table 13: CSF Management, New Zealand, Average Price ($), Forecast, 2011-2018
Table 14: CSF Management, New Zealand, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 15: CSF Management, New Zealand, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 16: Interventional Neurology Market, New Zealand, Segment Contribution (%), 2011
Table 17: Interventional Neurology, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 18: Interventional Neurology, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 19: Embolic Systems, New Zealand, Revenue ($m*) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 20: Embolic Systems, New Zealand, Revenue ($m*) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 21: Navigational Systems, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 22: Navigational Systems, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 23: Interventional Neurology, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Table 24: Interventional Neurology, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Table 25: Embolic Systems, New Zealand, Volume (Units) by Sub-Segment, Historic, 2004-2011
Table 26: Embolic Systems, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Table 27: Navigational Systems, New Zealand, Volume (Units) by Sub-Segment, Historic, 2004-2011
Table 28: Navigational Systems, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Table 29: Interventional Neurology, New Zealand, Average Price ($), Historic, 2004-2011
Table 30: Interventional Neurology, New Zealand, Average Price ($), Forecast, 2011-2018
Table 31: Interventional Neurology, New Zealand, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 32: Interventional Neurology, New Zealand, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 33: Neurological Diagnostic Equipment Market, New Zealand, Segment Contribution (%), 2011
Table 34: Neurological Diagnostic Equipment, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 35: Neurological Diagnostic Equipment, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 36: Neurological Diagnostic Equipment, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Table 37: Neurological Diagnostic Equipment, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Table 38: Neurological Diagnostic Equipment, New Zealand, Average Price ($), Historic, 2004-2011
Table 39: Neurological Diagnostic Equipment, New Zealand, Average Price ($), Forecast, 2011-2018
Table 40: Neurological Diagnostic Equipment, New Zealand, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 41: Neurological Diagnostic Equipment, New Zealand, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 42: Neurostimulation Devices Market, New Zealand, Segment Contribution (%), 2011
Table 43: Neurostimulation Devices, New Zealand, Revenue ($m*) USD Constant, by Segment, Historic, 2004-2011
Table 44: Neurostimulation Devices, New Zealand, Revenue ($m*) USD Constant, by Segment, Forecast, 2011-2018
Table 45: Neurostimulation Devices, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Table 46: Neurostimulation Devices, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Table 47: Neurostimulation Devices, New Zealand, Average Price ($), Historic, 2004-2011
Table 48: Neurostimulation Devices, New Zealand, Average Price ($), Forecast, 2011-2018
Table 49: Neurostimulation Devices, New Zealand, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 50: Neurostimulation Devices, New Zealand, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 51: Neurosurgical Products Market, New Zealand, Segment Contribution (%), 2011
Table 52: Neurosurgical Products, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 53: Neurosurgical Products, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 54: Neurosurgical Products, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Table 55: Neurosurgical Products, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Table 56: Neurosurgical Products, New Zealand, Average Price ($), Historic, 2004-2011
Table 57: Neurosurgical Products, New Zealand, Average Price ($), Forecast, 2011-2018
Table 58: Neurosurgical Products, New Zealand, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 59: Neurosurgical Products, New Zealand, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 60: Neurology Devices Market Pipeline Products
LIST OF FIGURES
Figure 1: Neurology Devices, Market Segmentation
Figure 2: Neurology Devices, New Zealand, Overall Revenue ($m), USD Constant, 2004-2018
Figure 3: Neurology Devices Market, New Zealand, Revenue Mix ($m), 2011
Figure 4: Neurology Devices Market, New Zealand, Category Contribution (%), 2011
Figure 5: Neurology Devices, New Zealand, Cross-Category Analysis, 2004-2018
Figure 6: Neurology Devices, New Zealand, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 7: Neurology Devices, New Zealand, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 8: Neurology Devices, New Zealand, Company Share (%), 2011
Figure 9: CSF Management, Market Segmentation
Figure 10: CSF Management Market, New Zealand, Revenue Mix ($m), 2011
Figure 11: CSF Management Market, New Zealand, Segment Contribution (%), 2011
Figure 12: CSF Management, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 13: CSF Management, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 14: CSF Management, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Figure 15: CSF Management, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Figure 16: CSF Management, New Zealand, Company Share (%), 2011
Figure 17: Interventional Neurology, Market Segmentation
Figure 18: Interventional Neurology Market, New Zealand, Revenue Mix ($m), 2011
Figure 19: Interventional Neurology Market, New Zealand, Segment Contribution (%), 2011
Figure 20: Interventional Neurology, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 21: Interventional Neurology, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 22: Embolic Systems, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 23: Embolic Systems, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 24: Navigational Systems, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 25: Navigational Systems, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 26: Interventional Neurology, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Figure 27: Interventional Neurology, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Figure 28: Embolic Systems, New Zealand, Volume (Units) by Sub-Segment, Historic, 2004-2011
Figure 29: Embolic Systems, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Figure 30: Navigational Systems, New Zealand, Volume (Units) by Sub-Segment, Historic, 2004-2011
Figure 31: Navigational Systems, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Figure 32: Interventional Neurology, New Zealand, Company Share (%), 2011
Figure 33: Neurological Diagnostic Equipment, Market Segmentation
Figure 34: Neurological Diagnostic Equipment Market, New Zealand, Revenue Mix ($m), 2011
Figure 35: Neurological Diagnostic Equipment Market, New Zealand, Segment Contribution (%), 2011
Figure 36: Neurological Diagnostic Equipment, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 37: Neurological Diagnostic Equipment, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 38: Neurological Diagnostic Equipment, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Figure 39: Neurological Diagnostic Equipment, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Figure 40: Neurological Diagnostic Equipment, New Zealand, Company Share (%), 2011
Figure 41: Neurostimulation Devices, Market Segmentation
Figure 42: Neurostimulation Devices Market, New Zealand, Revenue Mix ($m), 2011
Figure 43: Neurostimulation Devices Market, New Zealand, Segment Contribution (%), 2011
Figure 44: Neurostimulation Devices, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 45: Neurostimulation Devices, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 46: Neurostimulation Devices, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Figure 47: Neurostimulation Devices, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Figure 48: Neurostimulation Devices, New Zealand, Company Share (%), 2011
Figure 49: Neurosurgical Products, Market Segmentation
Figure 50: Neurosurgical Products Market, New Zealand, Revenue Mix ($m), 2011
Figure 51: Neurosurgical Products Market, New Zealand, Segment Contribution (%), 2011
Figure 52: Neurosurgical Products, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 53: Neurosurgical Products, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 54: Neurosurgical Products, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Figure 55: Neurosurgical Products, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Figure 56: Neurosurgical Products, New Zealand, Company Share (%), 2011
Figure 57: Medtronic, Inc., Company Share (%),New Zealand Neurology Devices Market, 2011
Figure 58: Terumo Corporation, Company Share (%),New Zealand Neurology Devices Market, 2011
Figure 59: B. Braun Melsungen AG, Company Share (%),New Zealand Neurology Devices Market, 2011
Figure 60: Stryker Corporation, Company Share (%),New Zealand Neurology Devices Market, 2011
Figure 61: Nihon Kohden Corporation, Company Share (%),New Zealand Neurology Devices Market, 2011
Figure 62: DePuy, Inc., Company Share (%),New Zealand Neurology Devices Market, 2011
COMPANIES MENTIONED
Medtronic, Inc.
Terumo Corporation
B. Braun Melsungen AG
Stryker Corporation
Nihon Kohden Corporation
DePuy, Inc.
Boston Scientific Corporation
Integra LifeSciences Holdings Corporation
Compumedics Limited
Natus Medical Incorporated
CareFusion Corporation
Christoph Miethke GmbH & Co. KG
Cadwell Laboratories, Inc.
KARL STORZ GmbH & Co. KG
St. Jude Medical, Inc.
Sophysa S.A.
Covidien plc
